London, United Kingdom--(Newsfile Corp. - September 27, 2022) - Este Medical Group has been recognized by LUXLife as the winner of the Most Trusted Multi-Practice Clinic 2022. This is in recognition of the expertise and the ongoing effort of Este Medical Group to provide high-quality healthcare services such as Body Contouring, FUE Hair Transplant, HydraFacial, Fat Freezing, Laser Hair Regrowth, Laser Hair Removal, and lots more. Led by AI Global Media Ltd., the LUXLife award started in 2017 and has been presented to different clinics in the past.
It is noteworthy that the award was keenly contested by several multi-practice clinics in the country. Entries for the award opened in December 2021 and closed in March 2022. When announcing the opening of entries for the award, Victoria Cotton, one of the team members of AI Global Media Ltd., noted that the award is meant for pioneers and innovators in the health, beauty and wellness industry. This award recognizes their commitment to offering top-of-the-range products and services to various individuals around the globe.
After a few months, Este Medical Group was announced as the winner of this prestigious award. The group got a physical trophy, certificate and other things from LUXLife. While receiving the award, the representatives of Este Medical Group showed gratitude to all staff of the team for their dedication. They also thanked clients for their longstanding support. In the past years, Este Medical Group received numerous awards including 2021's Scottish Hair & Beauty Awards and Cosmetics Healthcare CEO of the Year 2021.
About Este Medical Group: Este Medical Group is a team that offers various cosmetic, beauty, and health services that improve the quality of life of numerous individuals. The award-winning group has been working in the industry for more than 25 years and boasts of having state-of-the-art clinics in the UK, Turkey, Italy, and other locations around the globe.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/138586
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.